𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin

✍ Scribed by L. Jeromin

Publisher
Springer Netherlands
Year
1982
Tongue
English
Weight
370 KB
Volume
14
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Testosterone metabolism in patients with
Testosterone metabolism in patients with advanced carcinoma of the prostate: A comparative in vivo study of the effect of oestrogen and anti-prolactin
✍ Jacobi, G.H. ;Sinterhauf, K. ;Kurth, K.-H. ;Altwein, J.E. πŸ“‚ Article πŸ“… 1978 πŸ› Springer 🌐 English βš– 551 KB

In the light of the high incidence of cardiovascular side effects with oestrogen therapy in patients with prostatic cancer, other medications altering androgen metabolism are under investigation. The influence of the anti-prolactin bromocriptin (CB157) on plasma kinetics of testosterone and on endog

Clinical features of patients who presen
Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL : The β€œPSA negative” patients
✍ Alison J. Birtle; Alex Freeman; John R. W. Masters; Heather A. Payne; Stephen J. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 1 views

## Background: Although < 1% of men present with prostate-specific antigen (psa)-negative prostate carcinoma, in that they have serum psa levels much lower than the tumor burden would suggest, such patients represent a management dilemma. to the authors' knowledge, little information exists in the